![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Tan, A. C. S.; Schwartz, R.; Anaya, D.; Chatziralli, I.; Yuan, M.; Cicinelli, M. V.; Faes, L.; Mustapha, M.; Phasukkijwatana, N.; Pohlmann, D.; Reynolds, R.; Rosenblatt, A.; Savastano, A.; Touhami, S.; Vaezi, K.; Ventura, C. V.; Vogt, D.; Ambati, J.; de Smet, M. D. und Loewenstein, A.
(2022):
Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations.
In: International Journal of Retina and Vitreous, Bd. 8, Nr. 1, 33
2016
Schmiedl, S.; Fischer, R.; Ibanez, L.; Fortuny, J.; Thürmann, P. A.; Ballarin, E.; Ferrer, P.; Sabate, M.; Rottenkolber, D.; Gerlach, R.; Tauscher, M.; Reynolds, R.; Hasford, Joerg und Rottenkolber, Marietta
(2016):
Tiotropium Respimat((R)) vs. HandiHaler((R)): Real-life usage and TIOSPIR trial generalizability.
In: British Journal of Clinical Pharmacology, Bd. 81, Nr. 2: S. 379-388
Afonso, A.; Schmiedl, S.; Becker, C.; Tcherny-Lessenot, S.; Primatesta, P.; Plana, E.; Souverein, P.; Wang, Y.; Korevaar, J. C.; Hasford, Joerg; Reynolds, R.; de Groot, M. C.; Schlienger, R.; Klungel, O. und Rottenkolber, Marietta
(2016):
A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.
In: European Journal of Clinical Pharmacology, Bd. 72, Nr. 9: S. 1105-1116
2015
Rottenkolber, Marietta; Voogd, E.; van Dijk, L.; Primatesta, P.; Becker, C.; de Groot, M. C.; Plana, E.; Alvarez, Y.; Durand, J.; Slattery, J.; Afonso, A.; Requena, G.; Huerta, C.; Alvarez, A.; de Abajo, F. J.; Tauscher, M.; Hasford, Joerg; Fischer, R.; Reynolds, R. und Schmiedl, S.
(2015):
Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.
In: Respiratory Medicine, Bd. 109, Nr. 7: S. 828-837